Zhdanov A M, Gukov A O, Termosesov S A
Ter Arkh. 1994;66(5):66-9.
The paper summarizes the experience on 27 implantations of sensory multiprogrammable pacemakers (two-chamber Synchrony-II and one-chamber Sensolog-III) produced by Siemens-Elema. The implantations were performed in the Moscow Cardiostimulation Center in 1993. Primary pacemaker implantation was performed in 19 patients, 8 patients needed the replacement of one-chamber pacemakers because of the power source exhaustion or circulatory insufficiency. The two-chamber pacemaker was implanted to 14 patients with a complete AV-block and chronotropic sinus node incompetence and to 4 patients with sick sinus syndrome in intact AV-conduction. In 6 patients the one-chamber pacemaker was implanted to stimulate the right ventricle. They had permanent bradysystolic auricular fibrillation and complete AV block with persistent or transitory tachysystolic auricular fibrillation. 3 patients with sick sinus syndrome received one-chamber pacemaker. The authors think their experience with sensory Siemens-Elema pacemakers positive.
本文总结了1993年在莫斯科心脏刺激中心植入27台西门子 - 埃莱玛公司生产的多程控感知起搏器(双腔Synchrony-II和单腔Sensolog-III)的经验。19例患者进行了初次起搏器植入,8例患者因电源耗尽或循环功能不全需要更换单腔起搏器。14例完全性房室传导阻滞和变时性窦房结功能不全患者以及4例房室传导完整的病态窦房结综合征患者植入了双腔起搏器。6例患者植入单腔起搏器以刺激右心室,他们患有永久性缓慢性心房颤动和完全性房室传导阻滞,并伴有持续性或短暂性快速性心房颤动。3例病态窦房结综合征患者接受了单腔起搏器治疗。作者认为他们使用西门子 - 埃莱玛感知起搏器的经验是积极的。